BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-6.2%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$20.6B
AUM Growth
+$20.6B
(-9.7%)
Cap. Flow
+$247M
Cap. Flow
% of AUM
1.2%
Top 10 Holdings %
Top 10 Hldgs %
83.49%
Holding
127
New
5
Increased
17
Reduced
7
Closed
5
Top Buys
| 1 |
Incyte
INCY
|
$117M |
| 2 |
Entrada Therapeutics
TRDA
|
$80.5M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$48.4M |
| 4 |
TSVT
2seventy bio
TSVT
|
$21.4M |
| 5 |
Travere Therapeutics
TVTX
|
$19.5M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$61.1M |
| 2 |
Fulgent Genetics
FLGT
|
$20.1M |
| 3 |
BLUE
bluebird bio
BLUE
|
$13.6M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
$12.9M |
| 5 |
Aurinia Pharmaceuticals
AUPH
|
$11.5M |
Sector Composition
| 1 | Healthcare | 98.2% |
